Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
Intraperitoneal administration of recombinant human erythropoietin
L. A. Frenken
, D. G. Struijk
, P. J. Coppens
, R. G. Tiggeler
, R. T. Krediet
, R. A. Koene
Other Departments
Affiliatie UvA
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intraperitoneal administration of recombinant human erythropoietin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Continuous Ambulatory Peritoneal Dialysis
100%
Intraperitoneal Drug Administration
100%
Body Weight
33%
University Hospital
33%
Side Effect
33%
Outpatient
33%
Peritonitis
33%
Dialysis Fluid
33%
Antihypertensive Agent
33%
Hematocrit
33%
Hemoglobin Determination
33%
Subcutaneous Injection
33%
Keyphrases
Intraperitoneal Administration
100%
RhEPO
100%
Continuous Ambulatory Peritoneal Dialysis
27%
Hemoglobin
18%
Peritoneal Dialysis Patients
18%
University Hospital
9%
Peritonitis
9%
Safer Alternatives
9%
Hematocrit
9%
Hemoglobin Concentration
9%
Antihypertensive Medication
9%
Dialysis Solutions
9%
Dialysis Facility
9%
Subcutaneous Administration
9%
Pharmacology, Toxicology and Pharmaceutical Science
Recombinant Erythropoietin
100%
Side Effect
9%
Antihypertensive Agent
9%
Peritonitis
9%
Subcutaneous Injection
9%
Dialysis Fluid
9%